DataMeds AI, Inc.
MEDS- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0002030763
No open-market purchases or sales by DataMeds AI, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $160.6K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in DataMeds AI, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −4 vs. Q1 2026
- Shares held
- 51.8K
- −2.08M (−97.6%) vs. Q1 2026
- Total value
- $160.6K
- −$44.7K (−21.8%) vs. Q1 2026
- New holders
- 5
- 0 more added
- Sold out
- 9
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MEDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $160.6K |
| Q1 2026 | 13 | $205.3K |
| Q4 2025 | 19 | $773.4K |
| Q3 2025 | 16 | $3.89M |
| Q2 2025 | 6 | $593.0K |
| Q1 2025 | 5 | $1.53M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding DataMeds AI, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $3 | 0.00% | +1 | New |
| Global Retirement Partners, LLC | 2 | $6 | 0.00% | +2 | New |
| Fortitude Family Office, LLC | 118 | $366 | 0.00% | +118 | New |
| Tower Research Capital LLC (TRC) | 678 | $2.10K | 0.00% | +678 | New |
| Barclays PLC | 723 | $2.24K | 0.00% | +723 | New |
| Vanguard Fiduciary Trust Co | 6,191 | $19.2K | 0.00% | −303,393−98.0% | Reduced |
| Vanguard Capital Management LLC | 11,085 | $34.4K | 0.00% | −593,141−98.2% | Reduced |
| Geode Capital Management, LLC | 12,467 | $38.6K | 0.00% | −698,299−98.2% | Reduced |
| Jane Street Group, LLC | 20,532 | $63.6K | 0.00% | −73,448−78.2% | Reduced |
| State Street Corp | 0 | $0 | 0.00% | −124,600−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −74,063−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −58,421−100.0% | Sold out |
| ACT Advisors, LLC. | 0 | $0 | 0.00% | −35,389−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −31,501−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −27,324−100.0% | Sold out |
| Valley Forge Investment Consultants Inc Adv | 0 | $0 | 0.00% | −22,988−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −20,293−100.0% | Sold out |
| Sentinus, LLC | 0 | $0 | 0.00% | −20,293−100.0% | Sold out |